STAT3 and hepatocellular carcinoma: In hepatocarcinoma (HCC), STAT3 is a pivotal oncogenic driver by transcriptionally activating genes involved in hepatocarcinogenesis, promoting cell cycle progression, angiogenesis, immunosuppression and inhibiting apoptosis.